Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

ClinicalTrials.gov ID: NCT06585410

Public ClinicalTrials.gov record NCT06585410. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 4:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized Study of Intralesional Cemiplimab Versus Primary Surgery in Participants With Early Stage Cutaneous Squamous Cell Carcinoma (CSCC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will test a study drug called cemiplimab to see if it can help treat early-stage Cutaneous Squamous Cell Carcinoma (CSCC), a type of skin cancer. Cemiplimab works by helping the immune system to kill cancer cells. It binds to a protein called Programmed cell Death-1 (PD-1) on the surface of certain immune cells. The main purpose of this study is to compare how well cemiplimab works compared to surgery, when injected into the lesion. The study is looking at: * The side effects cemiplimab might cause * How well cemiplimab works compared to surgery

Study identification

NCT ID
NCT06585410
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
369 participants

Conditions and interventions

Interventions

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 1, 2025
Primary completion
May 2, 2030
Completion
May 2, 2030
Last update posted
Aug 16, 2026

2025 – 2030

United States locations

U.S. sites
47
U.S. states
26
U.S. cities
46
Facility City State ZIP Site status
Medical Dermatology Specialists - Phoenix Phoenix Arizona 85006 Recruiting
Mayo Clinic - Arizona Scottsdale Arizona 85259 Recruiting
University of Arizona Cancer Center Tucson Arizona 85719 Recruiting
Arkansas Research Trials North Little Rock Arkansas 72117 Recruiting
UC San Diego Moores Cancer Center La Jolla California 92093 Recruiting
Profound Research, Dermatology Medical Group - Oceanside Oceanside California 92056 Recruiting
Stanford University Redwood City California 94063 Recruiting
Peak Dermatology, Aesthetics and Wellness Visalia California 93291 Recruiting
George Washington University Medical Faculty Associates Washington D.C. District of Columbia 20037 Recruiting
Life Clinical Trials Coral Springs Florida 33071 Recruiting
Dermatology Associates of the Palm Beaches, Integri Research at Dermatology Associates Delray Beach Florida 33445 Recruiting
University of South Florida Tampa Florida 33612 Recruiting
University of Chicago Medical Center Chicago Illinois 60637 Recruiting
Oak Dermatology Naperville Illinois 60563 Recruiting
Dawes Fretzin Clinical Research - Shadeland Ave. Indianapolis Indiana 46250 Withdrawn
Equity Medical, LLC Bowling Green Kentucky 42104 Withdrawn
US Dermatology Partners DBA DermAssociates, PC Rockville Maryland 20850 Recruiting
Northeast Dermatology Associates Beverly Massachusetts 01915 Recruiting
Dana-Farber Cancer Institute Boston Massachusetts 02215 Recruiting
MyMichigan Dermatologic Oncology Midland Michigan 48640 Recruiting
Somerset Skin Centre Troy Michigan 48084 Recruiting
Dermatology and Skin Cancer Center Lee's Summit Missouri 64064 Recruiting
Washington University in St. Louis - Center for Dermatologic and Cosmetic Surgery St Louis Missouri 63141 Recruiting
Las Vegas Dermatology Las Vegas Nevada 89144 Recruiting
StracSkin, PLLC Portsmouth New Hampshire 03801 Recruiting
Metropolitan Dermatology Clark New Jersey 07066 Withdrawn
University of New Mexico Albuquerque New Mexico 87102 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10021 Recruiting
Columbia University Medical Center - Herbert Irving Center for Dermatology and Skin Cancer - Herbert Irving Pavilion New York New York 10032 Recruiting
Rochester Dermatologic Surgery, P.C. Victor New York 14564 Recruiting
UNC Hospitals Dermatology and Skin Cancer Center at Southern Village Chapel Hill North Carolina 27516 Recruiting
Cleveland Clinic Cleveland Ohio 44195 Recruiting
Buckeye Dermatology - Springfield Office Springfield Ohio 45505 Recruiting
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 Recruiting
Dermatology Health Specialists Bend Oregon 97702 Recruiting
Oregon Health & Science University Portland Oregon 97239 Recruiting
Penn State Hershey Medical Center Hershey Pennsylvania 17033 Recruiting
Penn Medicine, Perelman Center For Advanced Medicine Philadelphia Pennsylvania 19104 Recruiting
Clinical Research Center of the Carolinas Charleston South Carolina 29407 Recruiting
The University of Texas at Austin Dell Medical School Ascension Medical Group Austin Texas 78701 Recruiting
Reveal Research Institute Dallas Texas 75235 Recruiting
The University of Texas MD Anderson Cancer Center Houston Texas 77030 Recruiting
Epiphany Dermatology Lewisville Texas 75056 Recruiting
Texas Dermatology and Laser Specialists San Antonio Texas 78218 Recruiting
Center for Clinical Studies at Webster Clear Lake Webster Texas 77598 Recruiting
University of Utah Hospital Salt Lake City Utah 84132 Recruiting
Vcu Massey Cancer Center Richmond Virginia 23298 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06585410, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 16, 2026 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06585410 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →